Skip to main content
FinSpry Logo
FinSpry
CGEN logo
CGEN
(NASDAQ)
Compugen Ltd.
$2.71-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Compugen (CGEN) Stock Price & Financial Analysis

Compugen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.70 - $2.78
52-Week High$3.24
52-Week Low$1.29
Open$2.73
Volume265.15K
Average Volume (3M)601.27K
Market Cap256.12M
Shares Outstanding93.82M
P/E Ratio (TTM)5.15
Forward P/E2.54
Price to Sales (P/S)3.52
Price to Book (P/B)2.49
EV/EBITDA2.53
Revenue (TTM)72.76M
Net Income (TTM)49.70M
Free Cash Flow (TTM)12.53M
EPS (TTM)$0.53
Profit Margin68.31%
Operating Margin66.13%
Return on Equity (ROE)48.38%
Debt to Equity0.03
50-Day MA$2.46
200-Day MA$1.84
52-Week Change117.42%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Compugen

What is the current stock price for CGEN?

As of the latest trading session, CGEN stock trades at $2.71. The 52-week range is $1.29–$3.24, with a day range of $2.70–$2.78.

What is the P/E ratio for CGEN?

Compugen's trailing P/E ratio is 5.2, meaning investors pay $5.2 for every $1 of annual earnings. The forward P/E is 2.5, reflecting analyst expectations for future earnings. Compugen operates in the Healthcare sector.

Does CGEN pay dividends?

Compugen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CGEN?

Based on 1 analyst, the consensus for CGEN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CGEN?

Compugen's market capitalization is $253.8M, classifying it as a micro-cap company. Compugen operates in the Healthcare sector within the Biotechnology industry.